References in periodicals archive ?
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multidrug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
At this time, the addition of darunavir or tipranavir to the GS 9137 study arms was permitted, following the availability of data demonstrating a lack of drug interactions between both protease inhibitors and GS 9137.
TORONTO -- The protease inhibitor tipranavir boosted with ritonavir and formulated as a suspension that is easier for children to swallow than big "horse pills"--is safe and effective against multidrug-resistant HIV in treatment-experienced children aged 2-18 years, Dr.
McCallister coordinated the design, conduct, and analysis of more than 20 Phase I, II, and III tipranavir development trials, culminating in the FDA and EMEA approval of APTIVUS for the treatment of HIV infection in treatment-experienced patients.
34,36) There are nine FDA-approved PIs: ritonavir, amprenavir, fosamprenavir, indinavir, lopinavir (manufactured in combination with ritonavir), nelfinavir, saquinavir, atazanavir, and tipranavir.
Tipranavir (Aptivus) is a new protease inhibitor that is already available for patients who have very resistant HIV.
With the exception of tipranavir, nothing will happen, and that is a real problem for these guys who need drugs on an ongoing basis.
245Mg 60000 12000031 Um Caps Moi Tipranavir 250Mg 1200 2400Zidovudinu M Caps 100Mg 32 40000 8000033 Zidovudinu M Sol.
Patients without a genotyping test performed in the 18 months prior to DRV-based therapy and those who received etravirine, tipranavir, maraviroc or vicriviroc concurrently with DRV were excluded, as these drugs were not then available through the Brazilian Public Health Care System.
New PIs such as darunavir (32) and tipranavir (33) have revolutionised the management of highly resistant patients overseas.
People starting a more highly active regimen take three or four recent antiretrovirals (enfuvirtide, maraviroc, darunavir, tipranavir, etravirine, and/or raltegravir) with or without two or more NRTIs for 96 weeks.